Symbols / BMGL $0.59 -1.71%
BMGL Chart
About
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Care Facilities | Market Cap | 11.13M |
| Enterprise Value | 8.04M | Income | -10.64M | Sales | 11.35M |
| Book/sh | 0.23 | Cash/sh | 0.52 | Dividend Yield | — |
| Payout | 0.00% | Employees | 82 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.98 | P/B | 2.62 | P/C | — |
| EV/EBITDA | -3.96 | EV/Sales | 0.71 | Quick Ratio | 1.22 |
| Current Ratio | 1.31 | Debt/Eq | 120.04 | LT Debt/Eq | — |
| EPS (ttm) | -0.50 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 27.30% | Earnings | — | ROA | -7.65% |
| ROE | -163.64% | ROIC | — | Gross Margin | 21.18% |
| Oper. Margin | -24.88% | Profit Margin | -93.67% | Shs Outstand | 18.79M |
| Shs Float | 6.02M | Short Float | 1.30% | Short Ratio | 2.61 |
| Short Interest | — | 52W High | 9.40 | 52W Low | 0.49 |
| Beta | — | Avg Volume | 41.35K | Volume | 16.27K |
| Target Price | — | Recom | None | Prev Close | $0.60 |
| Price | $0.59 | Change | -1.71% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.59
Latest analyst target
3. DCF / Fair value
$2.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.59
Low
—
High
—
Mean
—
- Basel Medical Group (BMGL) director Paul Freudenthaler files initial Form 3 - Stock Titan Wed, 04 Mar 2026 08
- Basel Medical Group Ltd Reaffirms Strong Financial Performance and Strategic Outlook Amid Share Price Volatility - Nasdaq hu, 29 May 2025 07
- Why Basel Medical Group Ltd (BMGL) Surged Last Week - Insider Monkey Sat, 31 May 2025 07
- Health care company's shares tumble after ambitious plan - Yahoo Finance Fri, 16 May 2025 07
- Basel Medical Group receives Nasdaq non-compliance notice - Investing.com Mon, 01 Dec 2025 08
- Basel Medical Gets Early IPO Lock-Up Release: New Share Offering Coming Soon - Stock Titan hu, 26 Jun 2025 07
- Singapore-Based Basel Medical Group Plans $1 Billion Bitcoin Acquisition via Share-Swap Amid 15% Share Price Drop - thedefiant.io Mon, 19 May 2025 21
- BMGL Stock Price and Chart — NASDAQ:BMGL - TradingView ue, 25 Feb 2025 19
- Basel Medical Group Ltd Announces Exclusive Negotiations for $1 Billion BTC Acquisition to Enhance Balance Sheet and Expand Healthcare Services in Asia - Nasdaq Fri, 16 May 2025 07
- Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down - RTTNews Wed, 26 Feb 2025 08
- Basel Medical Group Ltd Announces Strategic Purchase Agreement for 10,000 BTC to Diversify Treasury Reserves - Nasdaq hu, 22 May 2025 07
- BMGL - Basel Medical Group Ltd Latest Stock News & Market Updates - Stock Titan ue, 25 Feb 2025 22
- Basel Medical Group Ltd Appoints Keng Leong Fung (Raymond Fung) as A Director, Effective April 4, 2025 - marketscreener.com Fri, 04 Apr 2025 07
- Technical Analysis of Basel Medical Group Ltd (NASDAQ:BMGL) - TradingView Wed, 26 Feb 2025 01
- Singapore Healthcare Provider Basel Medical Raises $8.82M in Fresh Nasdaq IPO - Stock Titan Mon, 03 Mar 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -372.01K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.03 | 0.14 | 0.16 | 0.17 |
| NormalizedEBITDA | 25.27K | 3.11M | 2.93M | 3.28M |
| TotalUnusualItems | -11.15M | 0.00 | ||
| TotalUnusualItemsExcludingGoodwill | -11.15M | 0.00 | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -12.09M | 2.07M | 1.78M | 1.98M |
| ReconciledDepreciation | 1.18M | 528.73K | 557.13K | 575.92K |
| ReconciledCostOfRevenue | 2.53M | 2.25M | 2.34M | 2.18M |
| EBITDA | -11.12M | 3.11M | 2.93M | 3.28M |
| EBIT | -12.30M | 2.58M | 2.37M | 2.71M |
| NetInterestIncome | -120.68K | -176.24K | 56.98K | -74.16K |
| InterestExpense | 203.95K | 176.24K | 238.60K | 320.87K |
| InterestIncome | 83.27K | 0.00 | 295.59K | 246.71K |
| NormalizedIncome | -1.31M | 2.07M | 1.78M | 1.98M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -12.09M | 2.07M | 1.78M | 1.98M |
| TotalExpenses | 13.50M | 7.86M | 7.63M | 8.18M |
| RentExpenseSupplemental | 141.07K | 3.18K | 19.20K | 12.59K |
| DilutedAverageShares | 18.45M | 18.45M | 16.25M | |
| BasicAverageShares | 18.45M | 18.45M | 16.25M | |
| DilutedEPS | 0.11 | 0.10 | 0.12 | |
| BasicEPS | 0.11 | 0.10 | 0.12 | |
| DilutedNIAvailtoComStockholders | -12.09M | 2.07M | 1.78M | 1.98M |
| NetIncomeCommonStockholders | -12.09M | 2.07M | 1.78M | 1.98M |
| NetIncome | -12.09M | 2.07M | 1.78M | 1.98M |
| MinorityInterests | 501.00 | |||
| NetIncomeIncludingNoncontrollingInterests | -12.09M | 2.07M | 1.78M | 1.98M |
| NetIncomeContinuousOperations | -12.09M | 2.07M | 1.78M | 1.98M |
| TaxProvision | -417.39K | 331.76K | 348.28K | 408.48K |
| PretaxIncome | -12.51M | 2.40M | 2.13M | 2.39M |
| OtherIncomeExpense | -10.20M | 385.69K | 71.67K | -13.59K |
| OtherNonOperatingIncomeExpenses | 943.89K | 385.69K | 71.67K | -13.59K |
| SpecialIncomeCharges | -11.15M | 0.00 | ||
| ImpairmentOfCapitalAssets | 11.15M | 0.00 | ||
| NetNonOperatingInterestIncomeExpense | -120.68K | -176.24K | 56.98K | -74.16K |
| InterestExpenseNonOperating | 203.95K | 176.24K | 238.60K | 320.87K |
| InterestIncomeNonOperating | 83.27K | 0.00 | 295.59K | 246.71K |
| OperatingIncome | -2.18M | 2.20M | 2.07M | 2.47M |
| OperatingExpense | 10.98M | 5.61M | 5.29M | 6.01M |
| OtherOperatingExpenses | 3.26M | 1.49M | 1.47M | 1.39M |
| ProvisionForDoubtfulAccounts | 0.00 | -55.74K | 0.00 | |
| DepreciationAmortizationDepletionIncomeStatement | 1.18M | 528.73K | 557.13K | 575.92K |
| DepreciationAndAmortizationInIncomeStatement | 1.18M | 528.73K | 557.13K | 575.92K |
| DepreciationIncomeStatement | 1.18M | 528.73K | 557.13K | 575.92K |
| SellingGeneralAndAdministration | 6.54M | 3.64M | 3.27M | 4.04M |
| GeneralAndAdministrativeExpense | 6.54M | 3.64M | 3.27M | 4.04M |
| RentAndLandingFees | 141.07K | 3.18K | 19.20K | 12.59K |
| SalariesAndWages | 6.40M | 3.64M | 3.25M | 4.03M |
| GrossProfit | 8.79M | 7.80M | 7.36M | 8.48M |
| CostOfRevenue | 2.53M | 2.25M | 2.34M | 2.18M |
| TotalRevenue | 11.32M | 10.05M | 9.70M | 10.66M |
| OperatingRevenue | 11.32M | 10.05M | 9.70M | 10.66M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 18.79M | 18.45M | 18.45M | 18.45M |
| ShareIssued | 18.79M | 18.45M | 18.45M | 18.45M |
| NetDebt | 2.31M | 5.40M | 7.38M | |
| TotalDebt | 3.42M | 4.29M | 7.21M | 10.15M |
| TangibleBookValue | 4.86M | 7.56M | 5.49M | 3.71M |
| InvestedCapital | 4.92M | 11.82M | 12.11M | 12.65M |
| WorkingCapital | 2.43M | 9.01M | 8.31M | 8.47M |
| NetTangibleAssets | 4.86M | 7.56M | 5.49M | 3.71M |
| CapitalLeaseObligations | 3.36M | 28.50K | 594.54K | 1.21M |
| CommonStockEquity | 4.86M | 7.56M | 5.49M | 3.71M |
| TotalCapitalization | 4.86M | 9.15M | 8.88M | 9.02M |
| TotalEquityGrossMinorityInterest | 4.86M | 7.56M | 5.49M | 3.71M |
| MinorityInterest | 3.50K | 0.00 | ||
| StockholdersEquity | 4.86M | 7.56M | 5.49M | 3.71M |
| GainsLossesNotAffectingRetainedEarnings | -24.95M | -24.46M | 0.00 | |
| OtherEquityAdjustments | -24.46M | -24.46M | ||
| ForeignCurrencyTranslationAdjustments | -495.74K | 0.00 | 0.00 | |
| RetainedEarnings | -4.40M | 7.56M | 5.49M | 3.71M |
| CapitalStock | 34.21M | 24.46M | 8.00 | 8.00 |
| CommonStock | 34.21M | 24.46M | 8.00 | 8.00 |
| TotalLiabilitiesNetMinorityInterest | 11.99M | 8.75M | 9.89M | 13.14M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.30M | 1.58M | 3.42M | 5.95M |
| LongTermDebtAndCapitalLeaseObligation | 1.30M | 1.58M | 3.42M | 5.95M |
| LongTermCapitalLeaseObligation | 1.30M | 0.00 | 28.50K | 638.48K |
| LongTermDebt | 1.58M | 3.40M | 5.31M | |
| CurrentLiabilities | 10.69M | 7.16M | 6.47M | 7.19M |
| CurrentDeferredLiabilities | 0.00 | 443.31K | 475.73K | 390.50K |
| CurrentDeferredTaxesLiabilities | 0.00 | 443.31K | 475.73K | 390.50K |
| CurrentDebtAndCapitalLeaseObligation | 2.12M | 2.71M | 3.79M | 4.20M |
| CurrentCapitalLeaseObligation | 2.06M | 28.50K | 566.04K | 574.44K |
| CurrentDebt | 61.37K | 2.68M | 3.22M | 3.63M |
| OtherCurrentBorrowings | 2.68M | 3.22M | 3.63M | |
| LineOfCredit | 61.37K | 0.00 | ||
| CurrentProvisions | 15.00K | 15.00K | 15.00K | 15.00K |
| PayablesAndAccruedExpenses | 8.56M | 4.00M | 2.19M | 2.58M |
| CurrentAccruedExpenses | 1.56M | 1.07M | 200.28K | 736.85K |
| Payables | 7.00M | 2.92M | 1.99M | 1.85M |
| OtherPayable | 2.98M | 280.43K | 416.36K | 440.29K |
| DuetoRelatedPartiesCurrent | 1.64M | 1.42M | 0.00 | 171.84K |
| TotalTaxPayable | 279.64K | 391.33K | 107.38K | 156.07K |
| AccountsPayable | 2.10M | 829.32K | 1.46M | 1.08M |
| TotalAssets | 16.85M | 16.31M | 15.38M | 16.85M |
| TotalNonCurrentAssets | 3.74M | 134.98K | 606.35K | 1.18M |
| NonCurrentDeferredAssets | 281.98K | 77.00K | 27.57K | 4.24K |
| NonCurrentDeferredTaxesAssets | 281.98K | 77.00K | 27.57K | 4.24K |
| InvestmentsAndAdvances | 49.00 | 0.00 | ||
| LongTermEquityInvestment | 49.00 | 0.00 | ||
| InvestmentsinAssociatesatCost | 49.00 | 0.00 | ||
| NetPPE | 3.45M | 57.97K | 578.78K | 1.18M |
| AccumulatedDepreciation | -6.55M | -3.74M | -3.21M | -2.70M |
| GrossPPE | 10.00M | 3.80M | 3.79M | 3.88M |
| OtherProperties | 9.22M | 3.29M | 3.29M | 3.38M |
| MachineryFurnitureEquipment | 782.75K | 506.25K | 498.33K | 496.94K |
| CurrentAssets | 13.12M | 16.17M | 14.77M | 15.67M |
| CurrentDeferredAssets | 31.80K | 1.59M | 0.00 | |
| PrepaidAssets | 7.24M | 118.42K | 133.78K | 149.24K |
| Inventory | 376.29K | 72.03K | 94.60K | 69.83K |
| FinishedGoods | 376.29K | 72.03K | 94.60K | 69.83K |
| Receivables | 2.49M | 12.44M | 13.33M | 13.88M |
| OtherReceivables | 206.39K | 213.64K | 15.66K | 117.96K |
| DuefromRelatedPartiesCurrent | 0.00 | 10.56M | 11.88M | 11.75M |
| AccountsReceivable | 2.29M | 1.67M | 1.44M | 2.01M |
| AllowanceForDoubtfulAccountsReceivable | -993.52K | -460.41K | -465.99K | -317.62K |
| GrossAccountsReceivable | 3.28M | 2.13M | 1.90M | 2.33M |
| CashCashEquivalentsAndShortTermInvestments | 2.98M | 1.95M | 1.22M | 1.56M |
| CashAndCashEquivalents | 2.98M | 1.95M | 1.22M | 1.56M |
| CashFinancial | 2.98M | 1.95M | 1.22M | 1.56M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -4.40M | 2.50M | 2.59M | 2.70M |
| RepaymentOfDebt | -9.24M | -2.92M | -2.94M | -3.09M |
| IssuanceOfDebt | 4.06M | 0.00 | 0.00 | 1.03M |
| IssuanceOfCapitalStock | 9.75M | 0.00 | ||
| CapitalExpenditure | -54.76K | -7.92K | -6.16K | -88.50K |
| EndCashPosition | 2.98M | 1.95M | 1.22M | 1.56M |
| BeginningCashPosition | 1.95M | 1.22M | 1.56M | 11.78M |
| EffectOfExchangeRateChanges | -495.74K | 0.00 | ||
| ChangesInCash | 1.52M | 733.61K | -346.24K | -10.22M |
| FinancingCashFlow | 16.91M | -1.77M | -2.94M | -12.92M |
| CashFlowFromContinuingFinancingActivities | 16.91M | -1.77M | -2.94M | -12.92M |
| NetOtherFinancingCharges | 12.34M | 1.16M | 325.00 | -10.86M |
| NetCommonStockIssuance | 9.75M | 0.00 | ||
| CommonStockIssuance | 9.75M | 0.00 | ||
| NetIssuancePaymentsOfDebt | -5.18M | -2.92M | -2.94M | -2.06M |
| NetShortTermDebtIssuance | 61.37K | 0.00 | ||
| ShortTermDebtIssuance | 61.37K | 0.00 | ||
| NetLongTermDebtIssuance | -5.24M | -2.92M | -2.94M | -2.06M |
| LongTermDebtPayments | -9.24M | -2.92M | -2.94M | -3.09M |
| LongTermDebtIssuance | 4.00M | 0.00 | 0.00 | 1.03M |
| InvestingCashFlow | -11.04M | -7.92K | -6.16K | -88.50K |
| CashFlowFromContinuingInvestingActivities | -11.04M | -7.92K | -6.16K | -88.50K |
| NetBusinessPurchaseAndSale | -10.99M | 0.00 | ||
| PurchaseOfBusiness | -10.99M | 0.00 | ||
| NetPPEPurchaseAndSale | -54.76K | -7.92K | -6.16K | -88.50K |
| PurchaseOfPPE | -54.76K | -7.92K | -6.16K | -88.50K |
| OperatingCashFlow | -4.34M | 2.51M | 2.60M | 2.79M |
| CashFlowFromContinuingOperatingActivities | -4.34M | 2.51M | 2.60M | 2.79M |
| TaxesRefundPaid | -648.29K | -176.24K | -286.37K | -30.06K |
| InterestPaidCFO | -203.95K | -413.61K | -238.60K | -320.87K |
| ChangeInWorkingCapital | -3.25M | -4.82K | 286.80K | 81.37K |
| ChangeInPayablesAndAccruedExpense | 4.34M | 387.69K | -223.96K | 64.49K |
| ChangeInPayable | 4.34M | 387.69K | -223.96K | 64.49K |
| ChangeInInventory | -304.26K | 22.57K | -24.77K | 2.81K |
| ChangeInReceivables | -7.28M | -415.08K | 535.54K | 14.06K |
| OtherNonCashItems | 203.95K | 176.24K | -56.98K | 74.16K |
| ProvisionandWriteOffofAssets | -682.25K | -5.57K | 148.37K | 6.47K |
| AssetImpairmentCharge | 11.56M | 0.00 | 58.08K | 19.03K |
| DepreciationAmortizationDepletion | 1.18M | 528.73K | 557.13K | 575.92K |
| DepreciationAndAmortization | 1.18M | 528.73K | 557.13K | 575.92K |
| Depreciation | 1.18M | 528.73K | 557.13K | 575.92K |
| NetIncomeFromContinuingOperations | -12.51M | 2.40M | 2.13M | 2.39M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for BMGL
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|